HomeSLRX • NASDAQ
add
Salarius Pharmaceuticals Inc
Previous close
$5.27
Day range
$5.25 - $5.47
Year range
$4.55 - $108.00
Market cap
2.70M USD
Avg Volume
114.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 965.56K | -34.20% |
Net income | -957.82K | 32.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -964.46K | 34.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 794.89K | -75.71% |
Total assets | 1.39M | -60.81% |
Total liabilities | 2.22M | 88.59% |
Total equity | -829.72K | — |
Shares outstanding | 509.71K | — |
Price to book | — | — |
Return on assets | -129.36% | — |
Return on capital | 736.37% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -957.82K | 32.76% |
Cash from operations | -862.30K | 19.58% |
Cash from investing | — | — |
Cash from financing | -141.20K | -400.88% |
Net change in cash | -1.00M | 8.80% |
Free cash flow | -603.15K | 5.59% |
About
Founded
2014
Headquarters
Website
Employees
2
